Analysts expect that ReWalk Robotics Ltd (NASDAQ:RWLK) will report earnings of ($0.31) per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for ReWalk Robotics’ earnings, with the highest EPS estimate coming in at ($0.22) and the lowest estimate coming in at ($0.39). ReWalk Robotics posted earnings of ($0.47) per share in the same quarter last year, which indicates a positive year over year growth rate of 34%. The firm is expected to announce its next earnings report on Friday, February 16th.

On average, analysts expect that ReWalk Robotics will report full year earnings of ($1.11) per share for the current financial year, with EPS estimates ranging from ($1.22) to ($1.00). For the next year, analysts expect that the company will post earnings of ($1.26) per share, with EPS estimates ranging from ($1.27) to ($1.24). Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that follow ReWalk Robotics.

ReWalk Robotics (NASDAQ:RWLK) last issued its earnings results on Thursday, November 2nd. The medical device company reported ($0.22) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.32) by $0.10. The business had revenue of $1.70 million for the quarter, compared to the consensus estimate of $1.63 million. ReWalk Robotics had a negative net margin of 346.14% and a negative return on equity of 568.25%. The firm’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the previous year, the company earned ($0.62) earnings per share.

A number of brokerages recently weighed in on RWLK. Zacks Investment Research upgraded shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 target price on the stock in a report on Thursday, November 9th. Canaccord Genuity restated a “buy” rating and set a $3.00 target price on shares of ReWalk Robotics in a report on Monday, November 6th. Finally, Jefferies Group lowered their target price on shares of ReWalk Robotics from $8.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 3rd. One research analyst has rated the stock with a sell rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $3.00.

Several large investors have recently added to or reduced their stakes in the business. Advisor Group Inc. increased its holdings in shares of ReWalk Robotics by 1,495.6% in the third quarter. Advisor Group Inc. now owns 181,900 shares of the medical device company’s stock valued at $264,000 after purchasing an additional 170,500 shares during the last quarter. Essex Investment Management Co. LLC increased its holdings in shares of ReWalk Robotics by 328.7% in the third quarter. Essex Investment Management Co. LLC now owns 156,981 shares of the medical device company’s stock valued at $228,000 after purchasing an additional 120,362 shares during the last quarter. Finally, Renaissance Technologies LLC increased its holdings in shares of ReWalk Robotics by 61.7% in the first quarter. Renaissance Technologies LLC now owns 78,600 shares of the medical device company’s stock valued at $165,000 after purchasing an additional 30,000 shares during the last quarter. Hedge funds and other institutional investors own 3.23% of the company’s stock.

Shares of ReWalk Robotics (NASDAQ RWLK) remained flat at $$1.10 on Wednesday. The company’s stock had a trading volume of 258,494 shares, compared to its average volume of 959,107. ReWalk Robotics has a 12-month low of $1.05 and a 12-month high of $3.60. The company has a current ratio of 2.02, a quick ratio of 1.65 and a debt-to-equity ratio of 7.46.

COPYRIGHT VIOLATION WARNING: This story was published by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://www.dailypolitical.com/2017/12/16/rewalk-robotics-ltd-rwlk-expected-to-announce-earnings-of-0-31-per-share.html.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Get a free copy of the Zacks research report on ReWalk Robotics (RWLK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.